focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Thu, 19th Apr 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Allergan moves in as Shire rebuffs $63 bln Takeda bid-sources

LONDON/NEW YORK - Drugmaker Shire has rejected a thirdtakeover bid worth nearly $63 billion from Japan's TakedaPharmaceutical, although talks are continuing, while sources sayAllergan is also in competing negotiations. (SHIRE-M&A/TAKEDAPHARMA-BID (UPDATE 2), moved, by Greg Roumeliotis, Ben Hirschlerand Ben Martin, 550 words)

EXCLUSIVE-China looks to speed up chip plans as U.S. tradetensions boil -sources

BEIJING - China is looking to accelerate plans to developits domestic semiconductor market amid a fierce trade stand-offwith the United States and a U.S. ban on sales to Chinese phonemaker ZTE that has underscored the country's reliance onimported chips. (USA-TRADE/CHINA-CHIPS (EXCLUSIVE), moved, byElias Glenn and Cate Cadell, 600 words)

P&G to buy German Merck's consumer health unit for $4.2 bln

Procter & Gamble Co will acquire the consumer healthbusiness of Merck KGaA for $4.2 billion, giving it vitaminbrands such as Seven Seas and greater exposure to Latin Americanand Asian markets. (MERCK-M&A/P&G (UPDATE 3, PIX), moved, 450words)

MARKETS

Apple, P&G and chip stocks lead Wall St lower

U.S. stock are lower, pulled down by a broad-based slump intechnology stocks from Apple to chipmakers as well as a tumblein consumer staples such as Procter & Gamble. (USA-STOCKS/(UPDATE 3), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 830 words

Oil climbs on Saudi price ambitions and U.S. stocks draw

LONDON - Oil prices keep rising to their highest since late2014 as U.S. crude inventories decline, moving closer tofive-year averages, and after sources tell Reuters that topexporter Saudi Arabia aims to push prices even higher.(GLOBAL-OIL/ (UPDATE 7, PIX), updated throughout the day, 430words)

TRADE/ECONOMY

U.S. weekly jobless claims dip in latest week

WASHINGTON - New applications for U.S. unemployment benefitsfell last week, indicating continued job growth after a slowdownin March. (USA-ECONOMY/UNEMPLOYMENT, moved, 340 words)

China says ready to deal with any fallout from U.S. traderow

BEIJING - China is well prepared to handle any negativeeffects from its trade dispute with the United States, thecommerce ministry says, adding that Beijing's tariff hikes onU.S. imports will not have a big impact overall on its domesticindustries. (USA-TRADE/CHINA (WRAPUP 1, TV), moved, by YawenChen and Se Young Lee, 490 words)

Trump, Japan's Abe agree to intensify trade talks

PALM BEACH - U.S. President Donald Trump and Japanese PrimeMinister Shinzo Abe say they have agreed to intensify tradeconsultations between the two longtime allies, with an aim toexpand investment and trade between their countries.(USA-JAPAN/TRADE-IMBALANCES (UPDATE 3), moved, by Steve Holland,500 words)

COMPANIES

As Bon-Ton liquidates, U.S. department stores vie for itsshoppers

With the disappearance of Bon-Ton, which won courtpermission on Wednesday to liquidate, rivals such as Macy's Inc,J.C. Penney Co Inc and Kohls Corp will compete to keep longtimecustomers from turning to discounters like Walmart Inc or onlinejuggernaut Amazon.com Inc. (BON TON STORES-BANKRUPTCY/ (REPEAT),moved, by Tracy Rucinski and Melissa Fares, 480 words)

Nucor profit beats estimates on higher prices, shipments

Nucor Corp reported a higher-than-expected quarterly profitas its shipments and selling price increased, and the company,the No. 1 U.S. steelmaker by market value, forecast asignificant increase in second-quarter profit on a sequentialbasis. (NUCOR-RESULTS/ (UPDATE 1), moved, 210 words)

Market swings knock Blackstone earnings less than feared

Blackstone Group LP, the largest manager of alternativeassets such as private equity and real estate, on Thursdayreported a 20 percent drop in first-quarter earnings per sharebut still beat Wall Street's expectations, as a stock marketslump weighed on the value of its holdings. (BLACKSTONEGROUP-RESULTS/ (UPDATE 1), moved, by Joshua Franklin, 360 words)

China's ZTE removed chief compliance officer before U.S.sanction -source

HONG KONG - ZTE Corp's chief compliance and chief legalofficer was removed from his posts more than a month before theChinese telecom equipment maker was slapped with U.S. sanctionsthis week, a company source with direct knowledge of thesituation told Reuters. (USA-CHINA/ZTE (PIX), moved, by SijiaJiang, 370 words)

+ See also:

- USA-CHINA/ZTE-RIVALS, moved, by Olof Swahnberg and EricAuchard, 770 words

EXCLUSIVE-Facebook to put 1.5 billion users out of reach ofnew EU privacy law

SAN FRANCISCO - If a new European law restricting whatcompanies can do with people's online data went into effecttomorrow, almost 1.9 billion Facebook Inc users around the worldwould be protected by it. The online social network is makingchanges that ensure the number will be much smaller.(FACEBOOK-PRIVACY/EU (UPDATE 1, EXCLUSIVE, PIX), moved, by DavidIngram, 750 words)

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH - Swiss drugmaker Novartis' first quarterly resultsunder new Chief Executive Vas Narasimhan have been marred by aprized psoriasis treatment that disappointed and a sharp slumpin sales by its U.S. generics unit. (NOVARTIS-RESULTS/ (UPDATE4, PIX), moved, by John Miller, 610 words)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.